Ipilimumab vs Losartan
Ipilimumab vs Losartan: Overview
This comparison examines the pharmacological differences between Ipilimumab and Losartan.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Losartan: Angiotensin II receptor type 1 antagonist.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days; Losartan β 2 hours.
Chemical Properties
Molecular Formula: Losartan β C22H23ClN6O.
Molecular Weight: Losartan β 422.9200 g/mol.
Type: Ipilimumab β Antibody; Losartan β Small molecule.